CD8A and neoplasm: Although a high proportion of homologous repair deficiency tumours in OC exhibit a high tumour mutational burden (TMB), increased CD8+ lymphocyte infiltration, and high tumour antigen expression that can independently trigger an antitumour response [3,4,5], clinical studies of OC immunotherapy have not yielded satisfactory results.